Last reviewed · How we verify
Overactive bladder
Approved treatments
- Nuceiva · GlaxoSmithKline K.K.
Nuceiva works by blocking the release of acetylcholine, a neurotransmitter that transmits signals from nerve cells to muscles, thereby reducing muscle spasms and contractions. - Botox · Allergan
BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25.
Clinical guidelines
- FDA label — 1L
Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Overactive bladder patent landscape — cliff calendar, originator estates, attackable patents
- Overactive bladder treatment landscape brief
- Overactive bladder treatment updates RSS
Frequently asked questions about Overactive bladder
What drugs treat Overactive bladder?
Tracked treatments include Nuceiva, Botox.
What is the treatment for Overactive bladder?
Standard treatment for Overactive bladder includes Nuceiva, Botox. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Overactive bladder?
FDA label publishes guidelines for Overactive bladder. 1 guideline references tracked.
Related
- Treatment landscape: Overactive bladder patent cliff · Overactive bladder CI report
- Treatment: Nuceiva · GlaxoSmithKline K.K.
- Treatment: Botox · Allergan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing